GlassScriptPhysician profile
Oscar Maitas
NPI 1386908531
$22,152.55
in general payments reported to CMS, 2019-2025
34 companies · $3,704 in 2025
The $3,704 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $664 · 2020: $995 · 2021: $6,281 · 2022: $4,304 · 2023: $3,347 · 2024: $2,858 · 2025: $3,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,953 · Travel and Lodging: $3,790 · Education: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,952.79 |
| Travel and Lodging | $3,790.18 |
| Education | $166.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,888.91 | 2021-2025 | Triclip, Diamondback Coronary, Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $3,646.62 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Biotronik INC. | $2,383.00 | 2021-2023 | Acticor 7 Vr-T Dx |
| Medtronic, INC. | $1,422.70 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, In.Pact Admiral |
| Janssen Pharmaceuticals, INC | $1,233.00 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $878.79 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $852.90 | 2019-2024 | Farxiga |
| Amgen INC. | $836.38 | 2021-2024 | Repatha |
| Boston Scientific Corporation | $656.42 | 2020-2023 | S-Icd System Magnet |
| Shockwave Medical, INC | $612.96 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $571.06 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $533.57 | 2019-2023 | |
| Abiomed | $520.90 | 2021-2024 | Impella |
| Novo Nordisk INC | $258.17 | 2021-2024 | |
| Astellas Pharma US INC | $254.58 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $249.21 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $221.54 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $196.54 | 2022-2023 | Onpattro |
| Impulse Dynamics (USA) INC. | $149.47 | 2022 | |
| United Therapeutics Corporation | $119.78 | 2019 | |
| Lantheus Medical Imaging, INC. | $113.49 | 2021 | |
| Livanova USA, INC. | $94.49 | 2022-2023 | Tandemlife |
| Penumbra, INC. | $78.81 | 2023-2025 | Indigo System, Ruby Coil |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Actelion Pharmaceuticals US, INC. | $64.10 | 2021-2022 | |
| Eko Health, INC. | $59.98 | 2023 | |
| Baxter Healthcare | $38.39 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Inari Medical, INC. | $29.25 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lexicon Pharmaceuticals, INC. | $28.07 | 2024 | |
| Kestra Medical Technology Services, INC. | $22.93 | 2023 | Assure Wcd |
| Biosense Webster, INC. | $20.09 | 2022 | |
| Angiodynamics, INC. | $15.78 | 2020 | |
| Cook Medical LLC | $14.87 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Maitas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.